A Randomized Phase 1/2 Trial Evaluating the Addition of Tolinapant to Weekly Paclitaxel With or Without Bevacizumab in Patients With Recurrent Epithelial Ovarian Cancer

  • Kristen Zeligs

Press/Media

Period14 May 2024

Media coverage

1

Media coverage

  • TitleA Randomized Phase 1/2 Trial Evaluating the Addition of Tolinapant to Weekly Paclitaxel With or Without Bevacizumab in Patients With Recurrent Epithelial Ovarian Cancer
    Media name/outletPolitics, Law & Government Daily
    Country/TerritoryUnited States
    Date14/05/24
    PersonsKristen Zeligs
View all 1
View less